Expected Moves

Aegon's Q3 trading update focusing on operating capital generation from Transamerica and updates on the ongoing share buyback program.

Full-year 2026 results detailing final surplus capital levels, dividend declarations, and forward guidance on US mortality trends.

Management presentation outlining the next phase of capital allocation post the a.s.r. transaction wind-down and organic growth initiatives.

First-half 2027 financial results focusing on commercial real estate exposure within the general account and asset management net flows.